Skip to main content

Table 2 One-year risk of seizures in users of each cholinesterase inhibitor compared with memantine users

From: Association of cognitive enhancers and incident seizure risk in dementia: a population-based study

 

Before PSM (N = 144,179)

After PSM (N = 52,184)

 

OR

(95% CIs)

p

OR

(95% CIs)

p

Memantine

1.000

(Reference)

 

1.000

(Reference)

 

Donepezil

1.061

(0.973–1.158)

0.181

1.107

(1.007–1.217)

0.035

Rivastigmine

1.135

(0.960–1.343)

0.137

1.312

(1.093–1.574)

0.004

Galantamine

1.087

(0.935–1.264)

0.277

1.194

(1.014–1.406)

0.034

  1. PSM Propensity Score Matching, OR Odds Ratio, CI Confidence Interval
Back to article page

BMC Geriatrics

ISSN: 1471-2318

Contact us